Skip to content

Valaris VAL Warrants And Rights Outstanding

Warrants And Rights Outstanding at other companies

Toast logo
ToastTOST
$11M-42.1%
Joby Aviation logo
Joby AviationJOBY
$29.46M-51.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$308.19M+3,316%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
500K
Corvex
 logo
Corvex MOVE
458.7K-4.8%
Valaris logo
ValarisVAL
$16.4M0.0%

Other financials

Income statement

See full
Revenue$465.4M-25.0%
Gross profit$92.0M-55.3%
Operating income$20.0M-86.0%
Net income-$16.4M+56.7%
EPS (diluted)-$0.24+54.7%

Balance sheet

See full
Cash & equivalents$595.4M+31.2%
Total debt$1.2B-0.7%
Total equity$3.2B+43.2%
Total assets$5.4B+22.3%

Cash flow

See full
Operating cash flow$75.0M-51.9%
CapEx$100.9M+0.7%
Free cash flow-$25.9M-146%

Valuation

See full
Market cap$5.44B+143%
Enterprise value$6B+110%
P/E5.4×-1.8×
P/S2.5×+1.5×

Profitability

See full
Gross margin28.3%-1.3pp
Operating margin16%-3.0pp
Net margin45.4%+32.8pp
FCF margin-31.2%

Returns & leverage

See full
Return on equity37.4%+22.8pp
Debt / equity0.4×-0.2×
Current ratio1.5×-0.1×

Where this comes from

Reported directly by Valaris in its filing.

Tagged under the XBRL concept us-gaap:WarrantsAndRightsOutstanding.

The official record: Valaris’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Valaris's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Valaris's warrants and rights outstanding?
Valaris (VAL) reported warrants and rights outstanding of $16.4M in Q1 2026.
How has Valaris's warrants and rights outstanding changed year-over-year?
Valaris's warrants and rights outstanding decreased by 0.0% year-over-year, from $16.4M to $16.4M.
What does warrants and rights outstanding mean?
This metric quantifies the total potential equity dilution arising from outstanding warrants and rights that grant holders the option to purchase company shares at a specified price. It serves as a critical indicator for shareholders to evaluate potential future changes in capital structure and earnings per share dilution. Tracking this figure is essential for understanding the long-term impact of equity-linked financing instruments on existing ownership stakes.